synergy health sterilisation uk limited
synergy health sterilisation uk limited Company Information
Company Number
01771333
Website
https://www.isotron.comRegistered Address
2200 renaissance, basing view, basingstoke, hampshire, RG21 4EQ
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Telephone
01793891891
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
synergy health holdings ltd 100%
synergy health sterilisation uk limited Estimated Valuation
Pomanda estimates the enterprise value of SYNERGY HEALTH STERILISATION UK LIMITED at £57.9m based on a Turnover of £53.8m and 1.07x industry multiple (adjusted for size and gross margin).
synergy health sterilisation uk limited Estimated Valuation
Pomanda estimates the enterprise value of SYNERGY HEALTH STERILISATION UK LIMITED at £259.2m based on an EBITDA of £27.9m and a 9.3x industry multiple (adjusted for size and gross margin).
synergy health sterilisation uk limited Estimated Valuation
Pomanda estimates the enterprise value of SYNERGY HEALTH STERILISATION UK LIMITED at £196.6m based on Net Assets of £87.7m and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Synergy Health Sterilisation Uk Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Synergy Health Sterilisation Uk Limited Overview
Synergy Health Sterilisation Uk Limited is a live company located in basingstoke, RG21 4EQ with a Companies House number of 01771333. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in November 1983, it's largest shareholder is synergy health holdings ltd with a 100% stake. Synergy Health Sterilisation Uk Limited is a mature, large sized company, Pomanda has estimated its turnover at £53.8m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Synergy Health Sterilisation Uk Limited Health Check
Pomanda's financial health check has awarded Synergy Health Sterilisation Uk Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 2 areas for improvement. Company Health Check FAQs
7 Strong
2 Regular
2 Weak
Size
annual sales of £53.8m, make it larger than the average company (£1.6m)
£53.8m - Synergy Health Sterilisation Uk Limited
£1.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 11%, show it is growing at a faster rate (5.4%)
11% - Synergy Health Sterilisation Uk Limited
5.4% - Industry AVG
Production
with a gross margin of 55.4%, this company has a lower cost of product (44.1%)
55.4% - Synergy Health Sterilisation Uk Limited
44.1% - Industry AVG
Profitability
an operating margin of 43.8% make it more profitable than the average company (6.3%)
43.8% - Synergy Health Sterilisation Uk Limited
6.3% - Industry AVG
Employees
with 227 employees, this is above the industry average (15)
227 - Synergy Health Sterilisation Uk Limited
15 - Industry AVG
Pay Structure
on an average salary of £52.1k, the company has an equivalent pay structure (£47k)
£52.1k - Synergy Health Sterilisation Uk Limited
£47k - Industry AVG
Efficiency
resulting in sales per employee of £237.2k, this is more efficient (£111k)
£237.2k - Synergy Health Sterilisation Uk Limited
£111k - Industry AVG
Debtor Days
it gets paid by customers after 46 days, this is near the average (56 days)
46 days - Synergy Health Sterilisation Uk Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 18 days, this is quicker than average (33 days)
18 days - Synergy Health Sterilisation Uk Limited
33 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Synergy Health Sterilisation Uk Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (33 weeks)
0 weeks - Synergy Health Sterilisation Uk Limited
33 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 16.9%, this is a lower level of debt than the average (52.2%)
16.9% - Synergy Health Sterilisation Uk Limited
52.2% - Industry AVG
synergy health sterilisation uk limited Credit Report and Business Information
Synergy Health Sterilisation Uk Limited Competitor Analysis
Perform a competitor analysis for synergy health sterilisation uk limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
synergy health sterilisation uk limited Ownership
SYNERGY HEALTH STERILISATION UK LIMITED group structure
Synergy Health Sterilisation Uk Limited has 1 subsidiary company.
Ultimate parent company
CEDE & CO
#0149427
2 parents
SYNERGY HEALTH STERILISATION UK LIMITED
01771333
1 subsidiary
synergy health sterilisation uk limited directors
Synergy Health Sterilisation Uk Limited currently has 2 directors. The longest serving directors include Mr Michael Eaton (Aug 2016) and Mr John Ubbing (May 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Michael Eaton | England | 51 years | Aug 2016 | - | Director |
| Mr John Ubbing | England | 37 years | May 2023 | - | Director |
SYNERGY HEALTH STERILISATION UK LIMITED financials
Synergy Health Sterilisation Uk Limited's latest turnover from March 2023 is £53.8 million and the company has net assets of £87.7 million. According to their latest financial statements, Synergy Health Sterilisation Uk Limited has 227 employees and maintains cash reserves of £30 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Apr 2012 | Apr 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 53,847,000 | 48,366,000 | 40,774,000 | 39,797,000 | 34,926,000 | 32,062,000 | 28,671,000 | 27,285,000 | 25,287,000 | 24,473,000 | 23,290,000 | 23,857,000 | 22,615,000 | 21,233,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Cost Of Sales | 24,013,000 | 17,450,000 | 13,023,000 | 11,752,000 | 11,662,000 | 8,523,000 | 8,308,000 | 8,857,000 | 8,492,000 | |||||
| Gross Profit | 29,834,000 | 30,916,000 | 27,751,000 | 28,045,000 | 23,264,000 | 23,539,000 | 20,363,000 | 18,428,000 | 16,795,000 | |||||
| Admin Expenses | 6,274,000 | 11,630,000 | 12,812,000 | 13,972,000 | 11,972,000 | 13,619,000 | 14,071,000 | 6,445,000 | 5,557,000 | |||||
| Operating Profit | 23,560,000 | 19,286,000 | 14,939,000 | 14,073,000 | 11,292,000 | 9,920,000 | 6,292,000 | 11,983,000 | 11,238,000 | 10,429,000 | 9,658,000 | 9,231,000 | 7,867,000 | 6,002,000 |
| Interest Payable | 3,000 | 3,000 | 5,000 | 4,000 | 0 | 1,000 | 3,000 | 5,000 | 177,000 | 197,000 | 134,000 | 268,000 | 415,000 | 268,000 |
| Interest Receivable | 905,000 | 793,000 | 590,000 | 656,000 | 372,000 | 93,000 | 575,000 | 323,000 | 430,000 | 267,000 | 96,000 | 372,000 | 204,000 | 99,000 |
| Pre-Tax Profit | 24,462,000 | 20,076,000 | 15,524,000 | 14,725,000 | 11,664,000 | 10,012,000 | 28,558,000 | 12,301,000 | 11,491,000 | 10,499,000 | 9,620,000 | 9,335,000 | 9,266,000 | 8,486,000 |
| Tax | -4,657,000 | -4,749,000 | -3,295,000 | -3,462,000 | -2,772,000 | -3,211,000 | -1,824,000 | -2,163,000 | -2,205,000 | -1,973,000 | -1,781,000 | -2,425,000 | -1,455,000 | -1,262,000 |
| Profit After Tax | 19,805,000 | 15,327,000 | 12,229,000 | 11,263,000 | 8,892,000 | 6,801,000 | 26,734,000 | 10,138,000 | 9,286,000 | 8,526,000 | 7,839,000 | 6,910,000 | 7,811,000 | 7,224,000 |
| Dividends Paid | 18,000,000 | 15,327,000 | 0 | 0 | 0 | 0 | 46,599,000 | 0 | 0 | 0 | 14,296,000 | 3,000,000 | 5,959,000 | 9,753,000 |
| Retained Profit | 1,805,000 | 0 | 12,229,000 | 11,263,000 | 8,892,000 | 6,801,000 | -19,865,000 | 10,138,000 | 9,286,000 | 8,526,000 | -6,457,000 | 3,910,000 | 1,852,000 | -2,529,000 |
| Employee Costs | 11,832,000 | 11,557,000 | 11,354,000 | 10,108,000 | 9,141,000 | 8,005,000 | 7,297,000 | 6,638,000 | 6,499,000 | 6,135,000 | 6,132,000 | 6,179,000 | 6,988,000 | 6,964,000 |
| Number Of Employees | 227 | 222 | 222 | 193 | 204 | 196 | 195 | 188 | 184 | 187 | 189 | 196 | 194 | 191 |
| EBITDA* | 27,882,000 | 23,064,000 | 18,503,000 | 17,380,000 | 14,365,000 | 12,878,000 | 9,126,000 | 14,486,000 | 13,659,000 | 12,864,000 | 11,939,000 | 11,494,000 | 10,342,000 | 8,836,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Apr 2012 | Apr 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 43,228,000 | 38,267,000 | 34,246,000 | 31,454,000 | 29,556,000 | 29,000,000 | 30,443,000 | 29,091,000 | 21,207,000 | 21,812,000 | 21,461,000 | 20,641,000 | 20,780,000 | 20,921,000 |
| Intangible Assets | 60,000 | 93,000 | 126,000 | 487,000 | 192,000 | 225,000 | 258,000 | 291,000 | 307,000 | 338,000 | 299,000 | 323,000 | 347,000 | 371,000 |
| Investments & Other | 34,350,000 | 34,350,000 | 34,350,000 | 34,350,000 | 34,350,000 | 34,350,000 | 34,350,000 | 35,913,000 | 35,913,000 | 37,099,000 | 37,099,000 | 37,099,000 | 37,099,000 | 37,099,000 |
| Debtors (Due After 1 year) | 0 | 0 | 13,164,000 | 27,549,000 | 21,131,000 | 7,878,000 | 0 | 19,753,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 77,638,000 | 72,710,000 | 81,886,000 | 93,840,000 | 85,229,000 | 71,453,000 | 65,051,000 | 85,048,000 | 57,427,000 | 59,249,000 | 58,859,000 | 58,063,000 | 58,226,000 | 58,391,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 435,000 | 413,000 | 424,000 | 386,000 | 333,000 | 334,000 | 363,000 |
| Trade Debtors | 6,908,000 | 4,954,000 | 4,141,000 | 5,037,000 | 4,745,000 | 5,176,000 | 3,574,000 | 3,895,000 | 4,644,000 | 3,961,000 | 3,463,000 | 3,093,000 | 2,796,000 | 2,768,000 |
| Group Debtors | 20,535,000 | 26,910,000 | 22,873,000 | 1,061,000 | 5,077,000 | 2,702,000 | 202,000 | 158,000 | 11,835,000 | 20,884,000 | 5,772,000 | 6,552,000 | 15,098,000 | 9,850,000 |
| Misc Debtors | 456,000 | 900,000 | 644,000 | 562,000 | 620,000 | 507,000 | 1,467,000 | 440,000 | 506,000 | 316,000 | 351,000 | 598,000 | 1,466,000 | 609,000 |
| Cash | 30,000 | 3,340,000 | 1,182,000 | 1,942,000 | 1,278,000 | 724,000 | 665,000 | 1,335,000 | 277,000 | 1,369,000 | 0 | 1,348,000 | 0 | 2,964,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 27,929,000 | 36,104,000 | 28,840,000 | 8,602,000 | 11,720,000 | 9,109,000 | 5,908,000 | 6,263,000 | 17,675,000 | 26,954,000 | 9,972,000 | 11,924,000 | 19,694,000 | 16,554,000 |
| total assets | 105,567,000 | 108,814,000 | 110,726,000 | 102,442,000 | 96,949,000 | 80,562,000 | 70,959,000 | 91,311,000 | 75,102,000 | 86,203,000 | 68,831,000 | 69,987,000 | 77,920,000 | 74,945,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6,909,000 | 0 | 4,807,000 | 5,610,000 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 1,186,000 | 1,787,000 | 2,668,000 | 3,191,000 | 2,574,000 | 702,000 | 1,541,000 | 1,167,000 | 765,000 | 923,000 | 1,235,000 | 1,702,000 | 956,000 | 2,018,000 |
| Group/Directors Accounts | 5,237,000 | 8,253,000 | 1,144,000 | 8,157,000 | 15,116,000 | 10,983,000 | 4,600,000 | 4,258,000 | 218,000 | 20,858,000 | 5,084,000 | 5,485,000 | 5,886,000 | 4,996,000 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 8,248,000 | 10,717,000 | 11,058,000 | 7,480,000 | 7,323,000 | 6,174,000 | 6,331,000 | 7,148,000 | 5,904,000 | 5,274,000 | 5,388,000 | 6,648,000 | 4,563,000 | 3,110,000 |
| total current liabilities | 14,671,000 | 20,757,000 | 14,870,000 | 18,828,000 | 25,013,000 | 17,859,000 | 12,472,000 | 12,573,000 | 6,887,000 | 27,055,000 | 18,616,000 | 13,835,000 | 16,212,000 | 15,734,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9,727,000 | 9,100,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 3,162,000 | 2,427,000 | 1,769,000 | 1,934,000 | 1,653,000 | 1,407,000 | 4,020,000 | 4,471,000 | 4,180,000 | 4,403,000 | 4,026,000 | 3,540,000 | 3,485,000 | 3,641,000 |
| total long term liabilities | 3,162,000 | 2,427,000 | 1,769,000 | 1,934,000 | 1,653,000 | 1,407,000 | 4,020,000 | 4,471,000 | 4,180,000 | 4,403,000 | 4,026,000 | 3,540,000 | 13,212,000 | 12,741,000 |
| total liabilities | 17,833,000 | 23,184,000 | 16,639,000 | 20,762,000 | 26,666,000 | 19,266,000 | 16,492,000 | 17,044,000 | 11,067,000 | 31,458,000 | 22,642,000 | 17,375,000 | 29,424,000 | 28,475,000 |
| net assets | 87,734,000 | 85,630,000 | 94,087,000 | 81,680,000 | 70,283,000 | 61,296,000 | 54,467,000 | 74,267,000 | 64,035,000 | 54,745,000 | 46,189,000 | 52,612,000 | 48,496,000 | 46,470,000 |
| total shareholders funds | 87,734,000 | 85,630,000 | 94,087,000 | 81,680,000 | 70,283,000 | 61,296,000 | 54,467,000 | 74,267,000 | 64,035,000 | 54,745,000 | 46,189,000 | 52,612,000 | 48,496,000 | 46,470,000 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Apr 2012 | Apr 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 23,560,000 | 19,286,000 | 14,939,000 | 14,073,000 | 11,292,000 | 9,920,000 | 6,292,000 | 11,983,000 | 11,238,000 | 10,429,000 | 9,658,000 | 9,231,000 | 7,867,000 | 6,002,000 |
| Depreciation | 4,289,000 | 3,745,000 | 3,531,000 | 3,274,000 | 3,040,000 | 2,925,000 | 2,801,000 | 2,472,000 | 2,390,000 | 2,406,000 | 2,257,000 | 2,239,000 | 2,451,000 | 2,810,000 |
| Amortisation | 33,000 | 33,000 | 33,000 | 33,000 | 33,000 | 33,000 | 33,000 | 31,000 | 31,000 | 29,000 | 24,000 | 24,000 | 24,000 | 24,000 |
| Tax | -4,657,000 | -4,749,000 | -3,295,000 | -3,462,000 | -2,772,000 | -3,211,000 | -1,824,000 | -2,163,000 | -2,205,000 | -1,973,000 | -1,781,000 | -2,425,000 | -1,455,000 | -1,262,000 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | -435,000 | 22,000 | -11,000 | 38,000 | 53,000 | -1,000 | -29,000 | 363,000 |
| Debtors | -4,865,000 | -8,058,000 | 6,613,000 | 2,636,000 | 15,310,000 | 11,020,000 | -19,003,000 | 7,261,000 | -8,176,000 | 15,575,000 | -657,000 | -9,117,000 | 6,133,000 | 13,227,000 |
| Creditors | -601,000 | -881,000 | -523,000 | 617,000 | 1,872,000 | -839,000 | 374,000 | 402,000 | -158,000 | -312,000 | -467,000 | 746,000 | -1,062,000 | 2,018,000 |
| Accruals and Deferred Income | -2,469,000 | -341,000 | 3,578,000 | 157,000 | 1,149,000 | -157,000 | -817,000 | 1,244,000 | 630,000 | -114,000 | -1,260,000 | 2,085,000 | 1,453,000 | 3,110,000 |
| Deferred Taxes & Provisions | 735,000 | 658,000 | -165,000 | 281,000 | 246,000 | -2,613,000 | -451,000 | 291,000 | -223,000 | 377,000 | 486,000 | 55,000 | -156,000 | 3,641,000 |
| Cash flow from operations | 25,755,000 | 25,809,000 | 11,485,000 | 12,337,000 | -450,000 | -4,962,000 | 25,846,000 | 6,977,000 | 19,890,000 | -4,771,000 | 9,521,000 | 21,073,000 | 3,018,000 | 2,753,000 |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | -1,563,000 | 0 | -1,186,000 | 0 | 0 | 0 | 0 | 37,099,000 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -3,016,000 | 7,109,000 | -7,013,000 | -6,959,000 | 4,133,000 | 6,383,000 | 342,000 | 4,040,000 | -20,640,000 | 15,774,000 | -401,000 | -401,000 | 890,000 | 4,996,000 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9,727,000 | 627,000 | 9,100,000 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 902,000 | 790,000 | 585,000 | 652,000 | 372,000 | 92,000 | 572,000 | 318,000 | 253,000 | 70,000 | -38,000 | 104,000 | -211,000 | -169,000 |
| cash flow from financing | -1,815,000 | -558,000 | -6,250,000 | -6,173,000 | 4,600,000 | 6,503,000 | 979,000 | 4,452,000 | -20,383,000 | 15,874,000 | -405,000 | -9,818,000 | 1,480,000 | 62,926,000 |
| cash and cash equivalents | ||||||||||||||
| cash | -3,310,000 | 2,158,000 | -760,000 | 664,000 | 554,000 | 59,000 | -670,000 | 1,058,000 | -1,092,000 | 1,369,000 | -1,348,000 | 1,348,000 | -2,964,000 | 2,964,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6,909,000 | 6,909,000 | -4,807,000 | -803,000 | 5,610,000 |
| change in cash | -3,310,000 | 2,158,000 | -760,000 | 664,000 | 554,000 | 59,000 | -670,000 | 1,058,000 | -1,092,000 | 8,278,000 | -8,257,000 | 6,155,000 | -2,161,000 | -2,646,000 |
P&L
March 2023turnover
53.8m
+11%
operating profit
23.6m
+22%
gross margin
55.5%
-13.32%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
87.7m
+0.02%
total assets
105.6m
-0.03%
cash
30k
-0.99%
net assets
Total assets minus all liabilities
Similar Companies
synergy health sterilisation uk limited company details
company number
01771333
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
November 1983
age
41
accounts
Full Accounts
ultimate parent company
previous names
isotron limited (December 2011)
isotron public limited company (December 2007)
incorporated
UK
address
2200 renaissance, basing view, basingstoke, hampshire, RG21 4EQ
last accounts submitted
March 2023
synergy health sterilisation uk limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to synergy health sterilisation uk limited. Currently there are 0 open charges and 1 have been satisfied in the past.
synergy health sterilisation uk limited Companies House Filings - See Documents
| date | description | view/download |
|---|
